Skip to main content Skip to main navigation menu Skip to site footer
Page Header Logo
  • Home
  • About
    • About the Journal
    • Aims & scope
    • Editorial Board
    • Contact Information
  • Current
  • Archives
  • Indexing & Abstracting
  • For Authors
    • Author Guidelines
    • Peer Review Policy
    • Ethical Consideration
    • Publication Ethics and Malpractice Statement
    • Submissions
Search
  • Register
  • Login
  1. Home /
  2. Search

Advanced filters
Human Platelet lysate as a Xeno Free Alternative of Fetal bovine serum for the In Vitro Expansion of Human Mesenchymal Stromal Cells
Saeed Mohammadi, Mohsen Nikbakht, Ashraf Malek Mohammadi, Mahdi Zahed Panah, Mohammad Reza Ostadali, Hajar Nasiri, Ardeshir Ghavamzadeh
Published: 2016-06-28
Patterns of DNMT1 Promoter Methylation in Patients with Acute Lymphoblastic Leukemia
Tirdad Rahmani, Mehdi Azad, Bahram Chahardouli, Hajar Nasiri, Mousa Vatanmakanian, Saeid Kaviani
Published: 2016-12-29
A Review on Iron Chelators in Treatment of Iron Overload Syndromes
Naser Mobarra, Mehrnoosh Shanaki, Hassan Ehteram, Hajar Nasiri, Mehdi Sahmani, Mohsen Saeidi, Mehdi Goudarzi, Hoda Pourkarim, Mehdi Azad
Published: 2016-10-06
Short View of Leukemia Diagnosis and Treatment in Iran
Mehdi Azad, Ramin Bakhshi Biniaz, Mehdi Goudarzi, Naser Mobarra, Shaban Alizadeh, Hajar Nasiri, Ali Dehghani Fard, Saeid Kaviani, Mohamad Hossein Moghadasi, Mohammad Reza Sarookhani, Mousa Vatanmakan, Mehdi Sahmani
Efficient Differentiation of Human Induced Pluripotent Stem Cell (hiPSC) Derived Hepatocyte-Like Cells on hMSCs Feeder
Naser Mobarra, Masoud Soleimani, Fatemeh Kouhkan, Zahra Hesari, Reyhaneh Lahmy, Majid Mossahebi-Mohammadi, Ehsan Arefian, Zahra Jaafarpour, Hajar Nasiri, Reza Pakzad, Rezvan Tavakoli, Parvin Pasalar
Genetic Engineering in Hematopoietic Stem Cells for β-Hemoglobinopathies Treatment: Advances, Challenges, and Clinical Translation
Sahar Taebi, Fatemeh Eskandari, Masoumeh Kohandani, Tahereh Manoochehrabadi, Hajar Nasiri
Published: 2025-10-16
1 - 6 of 6 items


2024 CiteScore: 1.2

pISSN: 2008-3009
eISSN: 2008-2207

 

Editor-in-Chief:
Ardeshir Ghavamzadeh, MD.

Chairman:
Ghasem Janbabaei

 

This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE).

1.2
2024CiteScore
 
 
33rd percentile
Powered by  Scopus

 

SCImago Journal & Country Rank

Make a Submission
Information
  • Publication Fee
  • For Readers
  • For Authors
  • For Librarians
International Journal of Hematology-Oncology and Stem Cell Research (Quarterly), pISSN: 2008-3009, eISSN: 2008-2207
Tehran University of Medical Sciences, Tehran, Iran.

All the work in this journal are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source.